Singapore recommends lifetime HIV test for adults after spike in cases

Singapore's Ministry of Health (MOH) has moved to dramatically reshape its public health strategy, recommending a lifetime HIV test for all adults in a bold push to curb a persistent rise in new infections. This proactive measure comes on the heels of 2025 data showing 166 new HIV cases among residents, an incidence rate of 3.9 per 100,000, underscoring the urgent need for enhanced early detection and prevention efforts. The directive represents a significant pivot from targeted, risk-based screening towards universal screening, aiming to normalize testing and dismantle long-standing HIV stigma. The city-state's health authorities recognize that increased diagnosis rates are critical to achieving viral load suppression through Antiretroviral Therapy (ART), which not only improves individual health outcomes but also effectively prevents further transmission. This strategy aligns with global efforts championed by organizations like UNAIDS, which continue to press for aggressive action to meet ambitious eradication targets amidst ongoing global challenges. The policy's implementation will require robust public awareness campaigns and seamless integration into routine healthcare pathways, with health providers expected to proactively offer testing. Observers will be watching to see if Singapore's innovative approach sets a precedent for other nations grappling with similar epidemiological trends, particularly in Southeast Asia. The focus now shifts to how effectively the MOH can operationalize this widespread testing, overcome logistical hurdles, and ensure equitable access to treatment and preventative measures like Pre-Exposure Prophylaxis (PrEP).